Mark is a doctor, scientist, and serial entrepreneur. As a neurosurgeon, he treats patients with spinal cord injury. Mark is best known for discovering the importance of macrophages for brain regeneration, which led to the first regenerative medicine trial for degenerative cervical myelopathy, and for developing opti-ox, a gene targeting approach that enables faithful execution of genetic information in cells.
Also speaking
Event Info
Spotlight Roundtables
Take a look at the sample attendee list for Advanced Therapies Europe here.
8 August 2022